Norton Rose Fulbright’s 2024 Annual Litigation Trends Survey indicates that class actions involving antitrust, securities and bank and financial fraud have grown. 

In the wake of last year’s banking crisis, the share of organizations involved in bank or financial fraud class actions more than doubled, to 21% in 2023 from 9% in 2022.

In addition, 18% experienced a securities class action last year (up from 10% in 2022), and it is an area of future concern for 31% of organizations that experienced class actions in 2023.

Download the 2024 Annual Litigation Trends Survey for more details.

Key litigation trends

Cybersecurity and data protection

Cybersecurity and data protection

Forty percent of organizations saw their cybersecurity dispute exposure grow in 2023 as cyberattacks reached record levels.

United States | January 17, 2024
Intellectual property

Intellectual property

AI is a leading contributor to both cybersecurity exposure and IP vulnerabilities, with roughly half of respondents saying that increased use of AI will grow their exposure.

United States | January 17, 2024
Environmental, social and governance

Environmental, social and governance

One in 10 respondents experienced ESG-related litigation last year (compared to just 2 percent in 2022) – a development we anticipated in our 2023 report.

United States | January 17, 2024
Regulation and investigations

Regulation and investigations

A greater proportion of organizations were involved in regulatory proceedings in 2023 versus the previous year, with 61% of respondents involved in at least one.

United States | January 17, 2024
Litigation preparedness

Litigation preparedness

As organizations expect more legal disputes across the board in 2024, more than half expect to hire internally to meet demand – much higher than the 36% in 2022.

United States | January 17, 2024


Contacts

Steven D. Jansma
Steven D. Jansma
Head of Litigation and Disputes, United States
Email
steven.jansma@nortonrosefulbright.com
T: +1 210 270 9366
Andrea L. D'Ambra
Andrea L. D'Ambra
US Head of Technology and US Head of eDiscovery and Information Governance
Email
andrea.dambra@nortonrosefulbright.com
T: +1 212 318 3015
Mayling C. Blanco
Mayling C. Blanco
Deputy General Counsel, Compliance
Email
mayling.blanco@nortonrosefulbright.com
T: +1 212 318 3340
Art Licygiewicz
Art Licygiewicz
Partner
Email
art.licygiewicz@nortonrosefulbright.com
T: +1 214 855 8256
Rachel Roosth
Rachel Roosth
Partner
Email
rachel.roosth@nortonrosefulbright.com
T: +1 713 651 3734

Practice areas:

Recent publications

Publication

Understanding the impact of Medicare Advantage changes on providers

The Centers for Medicare and Medicaid (CMS) recently released important policy updates for the Medicare Advantage program, providing critical insights for providers into the new administration’s views on the Medicare Advantage program.

United States | April 16, 2025

Healthcare
biotech test tubes

Publication

Strategic asset search and evaluation in biopharma

Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

United States | April 16, 2025

Life sciences and pharmaceuticals
Why SPACs offer a robust alternative to IPO market amidst looming global trade war

Publication

SPACs: Alternative to IPO market amid looming global trade war

President Trump’s recent tariffs appear to have direct implications for initial public offering (IPO) activity in what was forecasted to be a blockbuster year for such markets.

United States | April 15, 2025

Mergers and acquisitions
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now